Over Twenty-Five Years of Commercial Leadership. Available Where It Matters Most.
Serving as a board director and senior strategic advisor to life science companies that need a deeply experienced commercial leader — in the boardroom and at the highest levels of strategic decision-making.
A career commercial leader and current board member for three public life science companies, Robert built his executive reputation leading brands and portfolios with full P&L responsibility — driving launches, developing new markets, and managing commercial strategy across the US and Europe at Novartis, Pfizer, Shionogi, and Trialbee. From frontline sales leadership to senior marketing and general management, he has lived every stage of the commercial lifecycle across large multinational pharmaceutical organizations, specialty and regional markets, and a high-growth SaaS healthtech platform. Through Stratfox Healthcare Group, he brings that operational depth — spanning traditional life sciences and technology-enabled commercial models — to a selective portfolio of board directorships and strategic advisory engagements, partnering with companies at the moments when commercial clarity and executive experience are most consequential.
What I Bring to the Table
Whether in a board directorship or a focused advisory engagement, the expertise is the same — grounded in decades of real commercial accountability across global life science and healthtech markets.
Commercial Strategy & Go-to-Market Leadership: Deep, earned expertise in building and executing commercial strategies across pharmaceutical, OTC, and medical device portfolios — from early positioning and segmentation through channel strategy, field force deployment, and revenue execution in the US and European markets.
Sales Leadership & Commercial Execution: Direct experience leading sales organizations and building the commercial infrastructure — incentive design, field force structure, key account management, and the performance culture — that translates strategy into market share.
Brand Leadership & P&L Management: A track record of owning brands — not just advising on them. Extensive experience as the marketing lead accountable for brand strategy, investment allocation, promotional mix, and commercial performance across complex, multi-indication and multi-market portfolios. A track record of owning brands — not just advising on them. Extensive experience as the marketing lead accountable for brand strategy, investment allocation, promotional mix, and commercial performance across complex, multi-indication and multi-market portfolios.
Corporate Governance & Board Leadership: Independent, experienced oversight informed by decades of executive accountability across public and private life science organizations. Substantive familiarity with board responsibilities, fiduciary obligations, committee structures, and the governance standards that define well-run public companies.
Launch Readiness & New Market Development: Practical, cross-functional leadership through product launches and market entry — including competitive readiness, commercial infrastructure build, pricing strategy, and the organizational alignment required to convert launch plans into sustained market results.
Digital Health & SaaS Commercial Innovation: Few commercial executives have led both traditional pharmaceutical portfolios and a high-growth SaaS healthtech platform. That dual fluency — in product-led growth models, recurring revenue dynamics, and digital clinical infrastructure — gives boards and executive teams a grounded, commercially rigorous perspective on digital strategy, healthtech partnerships, and technology-enabled commercial model innovation.
Working Together
Stratfox Healthcare Group engagements are selective by design. The current focus is board directorships with public life science companies and a limited number of high-level strategic advisory projects where deep commercial expertise can drive meaningful impact.
If you are building a board, navigating a commercial inflection point, or preparing for a major market move — this is the conversation to have early.